Cite

HARVARD Citation

    Pellerino, A. et al. (2021). P14.42 Neratinib for treatment of leptomeningeal metastases from HER2-positive breast cancer in extended access program: preliminary results. Neuro-oncology. p. ii46. [Online]. 
  
Back to record